Moexipril Hydrochloride

盐酸莫昔普利

Report date: 2022/08/16 20:00:19
NME

Base Information

Drug NameMoexipril Hydrochloride
Drug Alias Name莫昔普利Femipress莫西普利盐酸盐UnivascPerdix +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin-converting enzyme inhibitors
TargetsAngiotensin-converting enzyme
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1995/04/19
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesSchwarz Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUcb IncPaddock Laboratories IncTeva Pharmaceuticals Usa Inc
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeC09AA13
Related LinksWikipediaDrugBankKEGG